Trade Show News
Stay updated with the latest trade show news through detailed press releases. Learn about upcoming events, key highlights, and industry trends. Get insights into significant trade show announcements, exhibitor information, and post-event analyses.
May 29, 2026 at 10:19 AM
AM Best to Speak, Sponsor and Exhibit at the Philippine Insurance Summit
SINGAPORE--(BUSINESS WIRE)--AM Best will speak, sponsor and exhibit at the Philippine Insurance Summit on Wednesday, 3 June 2026 in Makati City, Philippines at the Fairmont Hotel. Johnathan Wong, senior market development analyst, AM Best, will discuss AM Best’s latest outlook on the Philippine non-life insurance segment at 11:40 AM. Additionally, Rob Curtis, managing director and chief executive officer of AM Best’s Singapore operations will also be in attendance for meetings. To arrange a mee...
May 29, 2026 at 9:00 AM
Newegg Returns to COMPUTEX 2026 with Largest Gamer Zone Yet, Live PC Builder Mod Simulator Showdown, and Debut of Newegg Simulator Builder
DIAMOND BAR, Calif.--(BUSINESS WIRE)--Newegg (Newegg Commerce, Inc., NASDAQ: NEGG), a global leader in computer and technology products, today announced its participation at the 2026 Taipei International Computer Show (COMPUTEX 2026), taking place June 2–5. Marking Newegg's 25th anniversary year, the showcase is the company's largest-ever Computex footprint, anchored by an expanded Gamer Zone, the debut of Newegg Simulator Builder, and an international PC Builder Championship featuring leading...
May 29, 2026 at 9:00 AM
Accelerant to Present at William Blair’s 46th Annual Growth Stock Conference
ATLANTA--(BUSINESS WIRE)--Accelerant (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced Jeff Radke, Chairman and Chief Executive Officer, will be presenting at the William Blair Growth Stock Conference on Wednesday, June 3, 2026 at 10:20 am Eastern Time. A live webcast of the presentation can be accessed from the investor relations section on the Company's website at www.investor.accelerant.a...
May 29, 2026 at 8:05 AM
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will participate in the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting, taking place May 29 – June 2, 2026 in Cleveland, Ohio. At the meeting, NeuroPace will highlight the expanding role of responsive neuromodulation in epilepsy care, including long-term clinical out...
May 29, 2026 at 8:00 AM
Okta to Present at Upcoming Investor Conferences
SAN FRANCISCO--(BUSINESS WIRE)--Okta, Inc. (Nasdaq: OKTA), the leading independent identity provider, today announced that a member of its management team is scheduled to participate in an upcoming investor conference. Details for the event are as follows: Evercore TMT Conference Wednesday, June 3, 2026 1:20 p.m. Pacific time (4:20 p.m. Eastern time) FBN Virtual Technology Conference Wednesday, June 10, 2026 11:30 a.m. Pacific time (2:30 p.m. Eastern time) The presentations will be webcast live...
May 28, 2026 at 4:30 PM
Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June
SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company dedicated to restoring vision, today announced that the company will present at the Eye Bank Association of America (EBAA) 2026 Annual Meeting, taking place in Indianapolis, Indiana, from June 3-6 and at the American-European Congress of Ophthalmic Surgery (AECOS) 2026 European Symposium, June 11-14 in Madrid, Spain. Aurion has been invited for the f...
May 28, 2026 at 4:15 PM
Nebius to present at BofA Global Technology conference
AMSTERDAM--(BUSINESS WIRE)--Nebius (NASDAQ: NBIS), the AI cloud company, today announced that Roman Chernin, co-founder and Chief Business Officer, will take part in a fireside chat at the BofA Securities 2026 Global Technology conference. The session is scheduled for June 3 at 1:20 p.m. (PDT) / 4:20 p.m. (EDT) / 10:20 p.m. (CEST). The registration link to the live webcast will be available on the company’s investor relations website at https://nebius.com/investor-hub. About Nebius Nebius, the...
May 28, 2026 at 4:05 PM
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in Nareit’s REITweek 2026 Investor Conference
TUSTIN, Calif.--(BUSINESS WIRE)--In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has issued a business update, which is available on the company’s website. In addition, Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Darrin Smith, the company’s Chief Investment Officer, and Lukas Hartwich, the company’s Executive Vice President of Finance, will participate in Nareit’s REITweek 2026 In...
May 28, 2026 at 4:05 PM
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 4th at 11:05 a.m. ET. A live webcast of Ironwood’s fireside chat will be accessible through the Investors & Media section of the company’s website at www.ironwoodpharma.com. A replay of the webcast will be available on Ironwood’s website following the conference. About Ironwood Pharmaceutic...
May 28, 2026 at 4:05 PM
Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that data on the long-term administration of its tralesinidase alfa enzyme replacement therapy (TA-ERT) for the treatment of Sanfilippo Syndrome Type B (MPS IIIB) will be presented at the 18th International MPS & Related Lysosomal...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.